Analyst Ratings for Alkermes (ALKS)
ALKS Rating Summary
ALKS Price Target Summary
- Highest: $27.00 (Citi)
- Lowest: $17.00 (Goldman Sachs)
- Average: $22.86
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$22.86 (-30.7%)
Avg. $ Target:
$22.86 (-30.7%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/26/2013 | BofA/Merrill Lynch | Downgrade | Underperform (Neutral) |
N/A (N/A) |
31.92 | 33.00 | 3.38% | Details |
| 4/22/2013 | Lazard Capital | Downgrade | Neutral (Buy) |
N/A (N/A) |
31.27 | 33.00 | 5.53% | Details |
| 4/18/2013 | Mizuho Securities | Downgrade | Neutral (Buy) |
N/A (N/A) |
29.72 | 33.00 | 11.04% | Details |
| 1/23/2013 | MKM Partners » Updated 4/17/2013 |
Downgrade | Neutral (Buy) |
25.00 (23.00) |
22.50 | 33.00 | 46.67% | Details |
| 1/17/2013 | Credit Suisse | New Coverage | Neutral (N/A) |
24.00 (N/A) |
22.19 | 33.00 | 48.72% | Details |
| 1/10/2013 | Morgan Stanley | Upgrade | Overweight (Equalweight) |
N/A (N/A) |
21.61 | 33.00 | 52.71% | Details |
| 10/26/2012 | Citi | New Coverage | Buy (N/A) |
27.00 (N/A) |
18.36 | 33.00 | 79.74% | Details |
| 9/26/2011 | Jefferies » Updated 3/22/2012 |
New Coverage | Buy (N/A) |
24.00 (N/A) |
15.55 | 33.00 | 112.22% | Details |
| 8/30/2011 | Caris & Co. | Upgrade | Buy (N/A) |
22.00 (N/A) |
16.33 | 33.00 | 102.08% | Details |
| 8/23/2011 | UBS | Upgrade | Buy (N/A) |
21.00 (N/A) |
14.63 | 33.00 | 125.56% | Details |
| 5/13/2011 | Cowen | Upgrade | Outperform (N/A) |
N/A (N/A) |
17.02 | 33.00 | 93.89% | Details |
| 5/10/2011 | Leerink Swann » Updated 5/10/2011 |
Upgrade | Outperform (N/A) |
N/A (N/A) |
15.19 | 33.00 | 117.25% | Details |
| 2/8/2011 | Goldman Sachs » Updated 5/18/2012 |
New Coverage | Neutral (N/A) |
17.00 (N/A) |
14.07 | 33.00 | 134.54% | Details |
